Dentaid SL
11
1
1
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
9%
1 trials in Phase 3/4
0%
0 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Comparative Effects of Two Oral Antiseptics Used as an Adjuvant in the Treatment of Periodontitis
Role: collaborator
Incidence of Peri-implant Mucositis in Patients With Treated Periodontitis
Role: collaborator
Effect of Cetylpyridinium Chloride (CPC) Rinse in Viral Upper Respiratory Tract Infections (vURTI)
Role: lead
Impact of a Newly Formulated Toothpaste in Tooth Staining Associated With Chlorhexidine Rinses
Role: collaborator
Antiseptic Mouth Rinses to Reduce Salivary Viral Load in COVID-19 Patients
Role: collaborator
Double-blind, Randomized, Parallel, Placebo-controlled Clinical Study to Evaluate the Viral Load of SARS-CoV-2 (COVID-19) in the Oral Cavity of SARS-CoV-2 Positive Subjects After the Use of a Mouthwash Containing Cetylpyridinium Chloride 0,07%.
Role: lead
Assessment of the Impact of Oral Intervention With Cetylpyridinium Chloride to Decrease SARS-CoV-2 Viral Load in Patients With COVID-19
Role: collaborator
Pilot Study to Evaluate Effect of CHX0.12/CPC 0.05 of SARS-CoV-2 Viral Load in COVID-19 Patients
Role: lead
Quality of Life and Sjögren Syndrome
Role: collaborator
Effects of a 0.03% CHX Mouth Rinse in Peri-implant Mucositis
Role: collaborator
Clinical Effects of Two New Chlorhexidine Digluconate Formulations: 0.12% and 0.03%.
Role: collaborator
All 11 trials loaded